Status:
COMPLETED
Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer Screening
Lead Sponsor:
University of La Laguna
Conditions:
Hepatitis C Virus Infection
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
The main purpose of the study is to compare the acceptance and viability of three strategies aimed to screen hepatitis C virus (HCV) infection in a birth cohort by: a) invitation letter offering HCV s...
Detailed Description
This is a prospective, randomized, study in which subjects of four different health areas will be invited to participate in three different screening strategies for HCV. Hepatologists from a tertiary...
Eligibility Criteria
Inclusion
- Age 50-70 years
- Subjects attending selected primary care centers
- Willing to participate (informed consent signed)
Exclusion
- \-
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
609 Patients enrolled
Trial Details
Trial ID
NCT04037046
Start Date
March 1 2019
End Date
November 1 2019
Last Update
April 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manuel Hernandez-Guerra, MD
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain, 38320